News
U.S. clears new lupus drug, blockbuster sales seenHealth officials cleared Benlysta, discovered by Human Genome Sciences Inc, to combat the disease that causes the immune system to attack joints and organs and has proved tough to study and treat. Shares of Human Genome, a money-losing company founded ... read more
Trading Human Genome Sciences' Pending FDA Decision
Human Genome Sciences (HGSI) is slated to receive a response from the FDA by Thursday, March 10, on whether or not its drug Benlysta is approved. I am trading this catalyst event using a Call butterfly spread with an overlaid tight long Call spread. ... read more
Scientists Make Discoveries in the Biology of Lupus
The discoveries come during a week when the FDA is expected to announce its decision on the biologic drug Benlysta, which could be the first drug approved to treat lupus in nearly 50 years. According to the Lupus Foundation of America, lupus affects ... read more
No comments:
Post a Comment